Check-Cap (MBAI) Cash & Equivalents Growth (3y) (2015 - 2025)
Check-Cap (MBAI) Cash & Equivalents Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -20.26% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 42.38% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 11.37% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 14.02% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -14.97% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -58.12% |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | 210.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 210.11% |
| Jun 30, 2025 | -54.16% |
| Dec 31, 2024 | 52.77% |
| Jun 30, 2024 | 19.52% |
| Dec 31, 2023 | 3.17% |
| Sep 30, 2023 | -19.38% |
| Jun 30, 2023 | -33.21% |
| Mar 31, 2023 | 33.82% |
| Dec 31, 2022 | 44.30% |
| Sep 30, 2022 | 9.14% |
| Jun 30, 2022 | 11.43% |
| Mar 31, 2022 | 11.74% |
| Dec 31, 2021 | 43.67% |
| Sep 30, 2021 | 67.62% |
| Jun 30, 2021 | 1.59% |
| Mar 31, 2021 | 49.59% |
| Dec 31, 2020 | -11.55% |
| Sep 30, 2020 | -1.15% |
| Jun 30, 2020 | -1.52% |
| Mar 31, 2020 | -9.22% |